Durata Therapeutics (FRA:DTA) Sale Of Property, Plant, Equipment : €0.00 Mil (TTM As of Sep. 2014)

View and export this data going back to . Start your Free Trial

What is Durata Therapeutics Sale Of Property, Plant, Equipment?

Durata Therapeutics's sale of property, plant, equipment for the three months ended in Sep. 2014 was €0.00 Mil. It means Durata Therapeutics gained €0.00 Mil from selling property, plant, and equipment. Durata Therapeutics's sale of property, plant, equipment for the trailing twelve months (TTM) ended in Sep. 2014 was €0.00 Mil.

Compared with last quarter (€0.00 Mil in Jun. 2014 ), Durata Therapeutics gained the same money from selling property, plant, and equipment in Sep. 2014 (€0.00 Mil).

Durata Therapeutics Sale Of Property, Plant, Equipment Historical Data

The historical data trend for Durata Therapeutics's Sale Of Property, Plant, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Durata Therapeutics Sale Of Property, Plant, Equipment Chart

Durata Therapeutics Annual Data

Trend

Dec11

Dec12

Dec13

Sale Of Property, Plant, Equipment

Durata Therapeutics Quarterly Data
	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14
Sale Of Property, Plant, Equipment	Get a 7-Day Free Trial							-	-	-	-	-

Durata Therapeutics Sale Of Property, Plant, Equipment Calculation

The amount earned to sell PPE.

Sale Of Property, Plant, Equipment for the trailing twelve months (TTM) ended in Sep. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

Durata Therapeutics Sale Of Property, Plant, Equipment Related Terms

Thank you for viewing the detailed overview of Durata Therapeutics's Sale Of Property, Plant, Equipment provided by GuruFocus.com. Please click on the following links to see related term pages.

Durata Therapeutics (FRA:DTA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Durata Therapeutics Inc (FRA:DTA) » Definitions » Sale Of Property, Plant, Equipment

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.duratatherapeutics.com

Durata Therapeutics Inc was incorporated under the laws of the State of Delaware on November 4, 2009. The Company, along with its subsidiaries, is a development stage pharmaceutical company focused on the development and commercialization of novel therapeutics for patients with infectious diseases and acute illnesses. The Company recently completed two global Phase 3 clinical trials with its lead product candidate, dalbavancin, for the treatment of patients with acute bacterial skin and skin structure infections, or ABSSSI. Dalbavancin is an intravenous antibiotic product candidate designed for once-weekly dosing.

Durata Therapeutics (FRA:DTA) Headlines

No Headlines